Italian real-world analysis on management and pattern of PCSK9 inhibitor use in the first six months of treatment

This randomized clinical trial demonstrated that preoperative administration of low-molecular-weight-heparin (LMWH) is safe and feasible for lung cancer patients preparing to receive minimally invasive surgery.

The authors concluded that among patients who had undergone gynecological laparoscopic surgery, the incidence of postoperative deep vein thrombosis (DVT) was high, and that this incidence can be reduced by targeting high-risk factors.